Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 9OTHER 5NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Recurrent Squamous Cell Lung Carcinoma 2Melanoma 2Hodgkin Disease 2Thymoma 1Small Cell Lung Carcinoma 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Inoperable œsophageal Cancer 1Gastric and Esophagogastric Junction Adenocarcinoma 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Brain Neoplasms 1Advanced Solid Tumors 1Adenocarcinoma 1

Interventions

Platinum 4Cisplatin 4Carboplatin 31,2-diaminocyclohexaneplatinum II citrate 3regorafenib 2pegfilgrastim 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Doxorubicin 2Docetaxel 2Bevacizumab 2trifluridine tipiracil drug combination 1pembrolizumab 1merphos 1dehydroftorafur 1X-Rays 1Vinblastine 1Trifluridine 1Taxes 1Specimen Handling 1Radiotherapy, Image-Guided 1Radiotherapy 1Radiation 1Nivolumab 1Nephroureterectomy 1N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1Methotrexate 1Irinotecan 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma × Nivolumab × Clear all
NCT04879368 2025-07-17

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Active not recruiting
450 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡